Diagnostic Contract Manufacturing Market Report 2026

Diagnostic Contract Manufacturing Market Overview

• Diagnostic Contract Manufacturing market size has reached to $35.81 billion in 2025 • Expected to grow to $66.08 billion in 2030 at a compound annual growth rate (CAGR) of 12.7% • Growth Driver: Rising Emphasis On Preventive Healthcare Drives Growth In Diagnostic Contract Manufacturing Market • Market Trend: Next-Generation Systems Support High-Throughput Clinical Testing • North America was the largest region in 2025.

What Is Covered Under Diagnostic Contract Manufacturing Market?

Diagnostic contract manufacturing refers to outsourcing manufacturing processes and services by diagnostic companies to specialized contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). It involves outsourcing manufacturing processes and services to specialized partners to streamline production, ensure quality compliance, and enhance cost efficiency for diagnostic companies. The main types of services in diagnostic contract manufacturing include device development and manufacturing services, quality management services, packaging and assembly services, and others. Device development and manufacturing services involve the design, development, and production of medical devices, including in vitro diagnostic devices and diagnostic imaging devices. The services are used for applications such as in-vitro diagnostic devices, diagnostic imaging devices, and others by end users, including medical device companies, pharmaceutical and biopharmaceutical companies, and others.

What Is The Diagnostic Contract Manufacturing Market Growth Forecast?

The diagnostic contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $66.08 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growth in diagnostic innovation, demand for rapid scale-up, automation adoption, regional manufacturing expansion, focus on resilient supply chains. Major trends in the forecast period include increasing outsourcing of diagnostic manufacturing, rising demand for regulatory-compliant manufacturing services, expansion of end-to-end cdmo capabilities, growing focus on cost optimization and scalability, adoption of automated and smart manufacturing processes.

Global Diagnostic Contract Manufacturing Market Segmentation

1) By Service: Device Development And Manufacturing Services, Quality Management Services, Packaging And Assembly Services, Other Services 2) By Application: In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Applications 3) By End User: Medical Device Companies, Pharmaceutical And Biopharmaceutical Companies, Other End Users Subsegments: 1) By Device Development And Manufacturing Services: Product Design And Prototyping, Regulatory Affairs And Compliance, Manufacturing And Assembly, Testing And Validation 2) By Quality Management Services: Quality Control And Assurance, Auditing And Inspection Services, Risk Management, Compliance And Certification Support 3) By Packaging And Assembly Services: Primary Packaging, Secondary Packaging, Sterilization Services, Custom Packaging Solutions 4) By Other Services: Supply Chain Management, Inventory Management, Logistics And Distribution, Aftermarket Services

What Is The Driver Of The Diagnostic Contract Manufacturing Market?

An increasing focus on preventive healthcare is expected to propel the growth of the diagnostic contract manufacturing market going forward. Preventive healthcare refers to measures taken to prevent the occurrence or development of disease, illness, or injury. The focus on preventive healthcare is due to rising healthcare costs, shifts in healthcare priorities, a rise in chronic diseases, and population aging. Diagnostic contract manufacturing contributes to increasing the focus on preventive healthcare by providing essential diagnostic tools and tests, offering customized solutions, ensuring quality and regulatory compliance, supporting scalability, and enabling cost-effective solutions for disease prevention and early intervention. For instance, in October 2025, according to Eurostat, a Luxembourg-based government agency, preventive care was the next largest category, representing 3.7% of all healthcare spending in the EU in 2023. Among member states, its share was highest in the Netherlands (5.2%) and lowest in Malta (0.9%). Therefore, the increasing emphasis on preventive healthcare is driving the growth of the diagnostic contract manufacturing industry.

Key Players In The Global Diagnostic Contract Manufacturing Market

Major companies operating in the diagnostic contract manufacturing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Jabil Inc., Flex Ltd., Becton Dickinson and Company (BD), Sekisui Diagnostics LLC, Sanmina Corporation, Celestica Inc., Nipro Medical Corporation, Philips-Medisize Corporation, Plexus Corp, West Pharmaceutical Services Inc., Benchmark Electronics Inc., Bio-Rad Laboratories, QIAGEN N.V., Kimball Electronics Inc., Integer Holdings Corporation, Bio-Techne Corporation, Nolato AB, Nova Biomedical Corporation, Meridian Bioscience Inc., Fujirebio Inc., Biokit S.A., Invetech Pty. Ltd., KMC Systems, Savyon Diagnostics Ltd., Prestige Diagnostics U.K. Ltd., Cenogenic Corporation, Avioq Inc.

Global Diagnostic Contract Manufacturing Market Trends and Insights

Major companies operating in the diagnostic contract manufacturing market are focusing on developing advanced solutions, such as one-stop chemiluminescence immunoassay (CLIA) platforms, to enhance assay sensitivity, streamline production workflows, and support the growing demand for high-throughput and precision diagnostic testing. A one-stop CLIA platform is a fully integrated model in which a contract manufacturer provides everything from core raw materials and reagent development to open-system analyzers and large-scale production capabilities, unlike traditional segmented manufacturing, where different vendors supply individual components. For instance, in April 2023, Fapon Biotech Inc., a China-based IVD solutions provider, launched its chemiluminescence one-stop solution strategy, introducing both compact and high-capacity open-system CLIA analyzers such as Shine i1000 and Shine i2000, along with a portfolio of more than 100 CLIA reagents covering tumor, cardiac, infectious disease, thyroid, and inflammation biomarkers. Designed to help diagnostic companies accelerate product launches and expand testing menus, the solution offers high-quality raw-material sourcing, flexible reagent-development support, reduced per-test costs, and stronger alignment with local manufacturing requirements.

What Are Latest Mergers And Acquisitions In The Diagnostic Contract Manufacturing Market?

In August 2023, RQM Ltd., a US-based MedTech service provider, acquired Kottmann GmbH for an undisclosed amount. Through this acquisition, RQM aims to enhance operational efficiency, accelerate client market entry, and solidify its position as a leading MedTech contract research organization (CRO) in Europe and globally. Kottmann GmbH is a Germany-based contract research organization (CRO) that conducts clinical studies with medical devices, in vitro diagnostics (IVDs), and pharmaceuticals.

Regional Outlook

North America was the largest region in the diagnostic contract manufacturing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diagnostic Contract Manufacturing Market?

The diagnostic contract manufacturing market includes revenues earned by entities through supply chain management, regulatory support, post-market surveillance, logistics, and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diagnostic Contract Manufacturing Market Report 2026?

The diagnostic contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic contract manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.